QA: AbbVie Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2020_AbbVie_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001551152, AbbVie Inc.

  xvar xval
0 AssetsCurrent 49,519,000,000
1 IntangibleAssetsNetIncludingGoodwill 34,253,000,000
2 PropertyPlantAndEquipmentNet 2,962,000,000
3 remainder_Assets 2,381,000,000
4 LiabilitiesCurrent 15,585,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 7,439,000,000
8 SellingGeneralAndAdministrativeExpense 6,942,000,000
9 ResearchAndDevelopmentExpense 6,792,000,000
10 remainder_Expenses -346,000,000
11 remainder_Revenues 33,266,000,000
12 remainder_NetIncome -4,557,000,000
13 remainder_ComprehensiveNetIncome -1,116,000,000
  yvar yval
0 Assets 89,115,000,000
1 Liabilities 15,585,000,000
2 Expenses 20,827,000,000
3 Revenues 33,266,000,000
4 StockholdersEquity 73,530,000,000
5 NetIncome 7,882,000,000
6 ComprehensiveNetIncome 7,324,000,000
7 BaseVar 82,233,000,000
8 EconomicCapitalRatio 2.56

Edgar->Model Mapping

Feature Distribution

Change over Time